Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis

Sikander Ailawadhi, Pooja Advani, Dongyun Yang, Radhika Ghosh, Abhisek Swaika, Vivek Roy, James M Foran, Gerardo Colon-Otero, Asher A Chanan Khan

Research output: Contribution to journalArticle

9 Scopus citations


BACKGROUND National Cancer Institute (NCI)/National Comprehensive Cancer Network (NCCN)-designated cancer centers (CCs) offer patients state-of-the-art treatment, but their impact on multiple myeloma (MM) patient outcomes has not been evaluated. METHODS Adult MM patients diagnosed between 1973 and 2011 were identified from the Surveillance, Epidemiology, and End Results database and were stratified by the county of residence at the time of diagnosis and the year of CC designation. The influence of NCI/NCCN CC access, race, and the year of diagnosis on overall survival (OS) was evaluated with a Cox regression model. RESULTS A statistically significant OS improvement was noted in patients diagnosed after 1995 with access to 2 or more NCI CCs overall (P =.002 for 1996-2002; P

Original languageEnglish (US)
Pages (from-to)618-625
Number of pages8
Issue number4
StatePublished - Feb 15 2016



  • multiple myeloma
  • National Cancer Institute (NCI) cancer center
  • National Comprehensive Cancer Network (NCCN) cancer center
  • overall survival

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this